OC-0270: QoL and toxicity of HDR prostate brachytherapy as monotherapy 19Gy single fraction:phase II trialAlfonso Gómez‐Iturriaga, P. Bilbao, Salvador Pedraza et al.|Radiotherapy and Oncology|2017Cited by 0